• Caspase-3 Fluorometric Assay Kit: Precision for Autophagy–Ap

  2026-07-26

  Discover how the Caspase-3 Fluorometric Assay Kit delivers unparalleled sensitivity for detecting cysteine-dependent aspartate-directed protease activity. This article uniquely explores practical assay decisions and the autophagy–apoptosis interface in cancer research.

• Berberrubine Inhibits Thrombosis via Vitamin K Cycle Regulat

  2026-07-25

  This study demonstrates that berberrubine, a major metabolite of berberine, inhibits thrombosis in mice by modulating the vitamin K catalytic cycle without increasing bleeding risk. Integrated metabolomics and molecular docking provide mechanistic insights, highlighting new directions for antithrombotic drug development.

• Carfilzomib (PR-171): Redefining Proteasome Inhibition in ES

  2026-07-24

  Explore how Carfilzomib (PR-171) advances the frontiers of proteasome inhibition, enabling multi-modal cell death and sensitization strategies in esophageal squamous cell carcinoma (ESCC). This article integrates mechanistic insights, protocol guidance, and strategic foresight for translational researchers, drawing on the latest preclinical breakthroughs and highlighting APExBIO’s commitment to research innovation.

• PDGF-BB and Smooth Muscle Dynamics: Translating Mechanisms t

  2026-07-24

  This thought-leadership article unpacks how murine recombinant PDGF-BB enables next-generation modeling of vascular remodeling, with a focus on integrating recent mechanistic findings in pulmonary hypertension. It provides translational researchers with mechanistic insights, practical assay guidance, and a vision for leveraging mitogenic signaling in disease modeling. Emphasis is placed on validated protocols, the evolving competitive landscape, and the strategic impact of APExBIO’s PDGF-BB, murine recombinant protein.

• Lithium-Driven Exosomal Wnt10a Secretion Enhances Osteogenes

  2026-07-23

  This study reveals that lithium promotes osteogenesis by increasing the exosomal secretion of Wnt10a from bone mesenchymal stem cells (BMSCs) through Rab11a trafficking, leading to activation of the Wnt/β-catenin signaling pathway. These mechanistic insights provide a foundation for optimizing exosome-based bone regeneration therapies and inform future research on targeted modulation of Wnt signaling.

• Bay 11-7821 (BAY 11-7082) in Inflammatory Signaling Pathway

  2026-07-23

  Bay 11-7821 (BAY 11-7082) empowers researchers to dissect inflammatory signaling and apoptosis regulation with precision. This guide distills practical workflows, troubleshooting, and novel applications—grounded in recent literature—to maximize reproducibility and insight in cancer and immunology studies.

• HyperPFU™ high-fidelity DNA polymerase: Practical PCR Guidan

  2026-07-22

  HyperPFU™ high-fidelity DNA polymerase is engineered for the reliable PCR amplification of long, GC-rich, or otherwise challenging DNA templates, where standard enzymes often fail due to low fidelity or processivity. It is best used for workflows demanding blunt-ended, high-accuracy products, such as cloning and high-throughput sequencing, but is not suitable for applications requiring 3'-A overhangs or sticky-end generation.

• Distinct Mechanisms of PARP1 Regulation by RSL3 in Ferroptos

  2026-07-22

  This study reveals that RSL3, a classical ferroptosis inducer, promotes apoptosis by modulating PARP1 via both caspase-dependent cleavage and inhibition of m6A-mediated translation. The findings illuminate previously unappreciated pathways of cell death integration, with direct implications for targeting PARPi-resistant tumors.

• Malate’s Strategic Role in TCA Cycle Research and Tumor Immu

  2026-07-21

  This thought-leadership article explores the mechanistic and translational significance of malate ((S)-2-hydroxysuccinic acid) in dissecting the metabolic-immune axis of cancer, particularly in the context of PDHA1 succinylation-driven immune evasion in cholangiocarcinoma. We bridge foundational TCA cycle biochemistry with innovative experimental workflows, discussing malate’s value as a research reagent and providing actionable guidance for translational investigators.

• T7 RNA Polymerase: Optimizing In Vitro Transcription Workflo

  2026-07-21

  T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, is revolutionizing in vitro transcription for applications from RNA vaccine production to RNAi research. This guide delivers actionable workflow enhancements, troubleshooting strategies, and data-driven insights, drawing on recent advances in self-amplifying RNA vaccines and practical research experiences.

• LDH Cytotoxicity Assay Kit: Precision in Cell Cytotoxicity M

  2026-07-20

  The LDH Cytotoxicity Assay Kit empowers researchers with a non-radioactive, highly sensitive platform for quantifying cell cytotoxicity and apoptosis. Its versatility and robust design make it ideal for cancer research, neurodegenerative disease models, and advanced biocompatibility assessments.

• Trichostatin A (TSA): Unveiling HDAC3–Ferroptosis Axis in Ca

  2026-07-20

  Explore how Trichostatin A (TSA), a potent HDAC inhibitor, uniquely enables interrogation of the HDAC3–NRF2–GPX4 ferroptosis pathway and cell cycle regulation in cancer. This article offers advanced insights and practical guidance for researchers seeking to exploit epigenetic vulnerabilities in oncology.

• HyperPFU™ high-fidelity DNA polymerase: Technical Use Guide

  2026-07-19

  HyperPFU™ high-fidelity DNA polymerase addresses the technical challenges of amplifying long, GC-rich, or otherwise difficult DNA templates with high fidelity and speed. It is ideal for workflows requiring blunt-ended, accurate PCR products, such as cloning and high-throughput sequencing, but should not be used when 3'-A overhangs or sticky ends are necessary.

• Enabling mRNA-Based Tumor Suppressor Therapy: ATP Solution i

  2026-07-18

  This article unpacks the mechanistic and strategic value of high-purity ATP Solution (100 mM) in the development and optimization of mRNA-based tumor suppressor therapies for bladder cancer. Drawing on recent advances in lipid nanoparticle-mediated p21 mRNA delivery, we bridge cutting-edge biological rationale with actionable guidance for translational researchers, highlighting how APExBIO’s ATP Solution enables reproducibility and precision in sensitive kinase, transcription, and phosphorylation workflows critical to next-generation cancer therapeutics.

• Q-VD-OPh: Pan-Caspase Inhibitor Workflows for Apoptosis Rese

  2026-07-17

  Q-VD-OPh empowers researchers to dissect apoptosis mechanisms with precision, offering robust caspase inhibition in both in vitro and in vivo systems. Its cell-permeable, irreversible action not only advances fundamental studies but also improves viability in sensitive applications like cryopreservation and neurodegenerative modeling.

8762 records 4/585 page Previous Next 12345 下5页 Last page